On the other hand, GzmB-mediated activation-induced death of CD4+ T cells inhibits murine acute GVHD (39), while GzmB contributes to the optimal graft-versus-tumor effect mediated by CD4+ T cells (40). The gene discussed is GZMB; the disease is neoplasm.